HCG 2000 IU (hCG)

Research interest in HCG 2000 IU research peptide centers on its effects on receptor activation, cAMP/PKA-linked signaling, steroidogenic output, and hormone-regulated cellular communication. hCG is also studied for its broader biological roles in angiogenesis, endometrial interaction, and immunoregulatory processes at the maternal-fetal interface. These features make it highly relevant in research models focused on implantation biology, corpus luteum support pathways, trophoblast-endometrial signaling, and comparative gonadotropin pharmacology. Structural studies further show that hCG activity is closely linked to its glycoprotein architecture, making it valuable in experiments examining how subunit composition and glycosylation influence receptor binding and signaling strength.

(Tsampalas et al., 2010 — Human Reproduction Update).

Current research applications for HCG 2000 IU research peptide include LHCGR signaling studies, steroidogenesis models, reproductive endocrinology assays, receptor-binding investigations, and glycoprotein hormone structure-function analysis. Researchers also use hCG in experimental systems to compare ligand-specific signaling differences between LH and hCG and to explore how glycosylation state may influence hormone stability, receptor selectivity, and biological response. As a result, hCG remains one of the best-characterized gonadotropin tools in endocrine and reproductive laboratory research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling. COA included with every order. See also: Tirzepatide, Semaglutide, AOD-9604